Unveiling the Anti‐Inflammatory Mechanism of Ziziphus jujuba Mill. var. spinosa Flowers: Network Pharmacology, Molecular Docking and Experimental Validation
Biomedical Chromatography · 2026-06 · 40 (6)
DOI: 10.1002/bmc.70446 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 20.04.2026. Verfasst von Yanan Fu und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China. Hauptthemen laut MEDLINE: Ziziphus, Anti-Inflammatory Agents, Plant Extracts. Die Arbeit nennt 47 Literaturangaben. Gefördert von: Shandong University of Traditional Chinese Medicine.
Abstract (Originalsprache)
During the cultivation of Ziziphus jujuba Mill. var. spinosa trees, two varieties exhibiting floral sterility were identified. Their flowers are often discarded, resulting in resource wastage. Therefore, non‐targeted metabolomics technology was employed to characterize the chemical composition of Z. jujuba Mill. var. spinosa flowers. Network pharmacology was then utilized to explore their medicinal active components and mechanisms of action, which were validated through molecular docking and in vitro anti‐inflammatory experiments. Results revealed that 3851 metabolites were identified in Z. jujuba Mill. var. spinosa flowers, with 23 potential compounds screened. Among these, 212 targets were directly involved in inflammatory responses. KEGG enrichment analysis suggested that Z. jujuba Mill. var. spinosa flowers may exert anti‐inflammatory effects through the TNF signaling pathway, Toll‐like receptor signaling pathway, Th17 cell differentiation, and hypoxia‐inducible factor‐1 pathway. Molecular docking results indicated that active components in Z. jujuba Mill. var. spinosa flowers exhibit good binding affinity with key inflammatory targets. In vitro anti‐inflammatory assays validated that the ethanol extract of Z. jujuba Mill. var. spinosa flowers reduces the expression of TNF‐α, IL‐1β, and IL‐6, thereby alleviating inflammation. This study preliminarily demonstrates that Z. jujuba Mill. var. spinosa flowers contain anti‐inflammatory active components, and the associated bioactive substances hold potential for development into anti‐inflammatory drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China.
- Key Laboratory of Traditional Chinese Medicine Classical Theory, Ministry of Education, Shandong University of Traditional Chinese Medicine, Jinan, China.
- Shandong Key Laboratory of Digital Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
- Jinan Academy of Agriculture Sciences, Jinan, China.
- Pingyin Agriculture and Rural Bureau, Pingyin, China.
- School of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
ORCID-Profile: Qingmei Guo
Förderung
- Shandong University of Traditional Chinese Medicine
Zitieren
APA
Fu, Y., Xu, C., Wan, J., Qiao, W., Yan, Q., Du, X., Ma, R., Li, J., & Guo, Q. (2026). Unveiling the Anti‐Inflammatory Mechanism of Ziziphus jujuba Mill. var. spinosa Flowers: Network Pharmacology, Molecular Docking and Experimental Validation. Biomedical Chromatography, 40(6). https://doi.org/10.1002/bmc.70446
Vancouver
Fu Y, Xu C, Wan J, Qiao W, Yan Q, Du X, et al. Unveiling the Anti‐Inflammatory Mechanism of Ziziphus jujuba Mill. var. spinosa Flowers: Network Pharmacology, Molecular Docking and Experimental Validation. Biomedical Chromatography. 2026;40(6). doi:10.1002/bmc.70446
BibTeX
@article{Fu2026,
author = {Fu, Yanan and Xu, Cuicui and Wan, Jiafu and Qiao, Wenyong and Yan, Qingyu and Du, Xianchen and Ma, Rongshen and Li, Jiayi and Guo, Qingmei},
title = {Unveiling the Anti‐Inflammatory Mechanism of Ziziphus jujuba Mill. var. spinosa Flowers: Network Pharmacology, Molecular Docking and Experimental Validation},
journal = {Biomedical Chromatography},
year = {2026},
volume = {40},
number = {6},
doi = {10.1002/bmc.70446}
}
EUVIMED